New England Research & Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Buy |
+1,225
| New | +$338K | 0.16% | 125 |
|
|
2024
Q4 | – | Sell |
-2,175
| Closed | -$480K | – | 151 |
|
|
2024
Q3 | $480K | Sell |
2,175
-900
| -29% | -$199K | 0.23% | 111 |
|
|
2024
Q2 | $605K | Buy |
+3,075
| New | +$605K | 0.29% | 106 |
|
|
2023
Q1 | – | Sell |
-6,275
| Closed | -$1.06M | – | 147 |
|
|
2022
Q4 | $1.06M | Buy |
6,275
+4,800
| +325% | +$807K | 0.61% | 61 |
|
|
2022
Q3 | $261K | Buy |
+1,475
| New | +$261K | 0.16% | 134 |
|
|
2022
Q1 | – | Sell |
-3,815
| Closed | -$872K | – | 169 |
|
|
2021
Q4 | $872K | Sell |
3,815
-1,485
| -28% | -$339K | 0.42% | 75 |
|
|
2021
Q3 | $1.03M | Buy |
+5,300
| New | +$1.03M | 0.54% | 65 |
|
|
2020
Q1 | – | Sell |
-3,505
| Closed | -$704K | – | 143 |
|
|
2019
Q4 | $704K | Buy |
3,505
+125
| +4% | +$25.1K | 0.47% | 77 |
|
|
2019
Q3 | $714K | Buy |
3,380
+2,150
| +175% | +$454K | 0.52% | 70 |
|
|
2019
Q2 | $239K | Sell |
1,230
-275
| -18% | -$53.4K | 0.16% | 148 |
|
|
2019
Q1 | $248K | Buy |
+1,505
| New | +$248K | 0.17% | 146 |
|
|
2017
Q3 | – | Sell |
-2,895
| Closed | -$363K | – | 161 |
|
|
2017
Q2 | $363K | Sell |
2,895
-200
| -6% | -$25.1K | 0.27% | 110 |
|
|
2017
Q1 | $368K | Buy |
+3,095
| New | +$368K | 0.28% | 110 |
|